For Immediate Release:
Statement From:
Commissioner of Food and Drugs – Food and Drug Administration

Stephen M. Hahn M.D.

Associate Commissioner for Regulatory Affairs – Office of Regulatory Affairs

Judith A. McMeekin Pharm.D.

The U.S. Food and Drug Administration is actively and aggressively monitoring the market for any firms marketing products with fraudulent coronavirus (COVID-19) diagnostic, prevention and treatment claims as part of our ongoing efforts to protect public health during this pandemic. As a result of these activities, the agency is beginning to see unauthorized fraudulent test kits that are being marketed to test for COVID-19 in the home.

For more information go to